Giancarlo Spinzi, Silvia Paggi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Benzenesulfonates/adverse effectsBenzenesulfonates/therapeutic useCarcinoma, Hepatocellular/drug therapyHumansHypertension/chemically inducedIncidenceLiver Neoplasms/drug therapyNiacinamide/analogs & derivativesPhenylurea CompoundsProtein Kinase Inhibitors/adverse effectsProtein Kinase Inhibitors/therapeutic usePyridines/adverse effectsPyridines/therapeutic useQuality of LifeSorafenib
Substances: See more » BenzenesulfonatesPhenylurea CompoundsProtein Kinase InhibitorsPyridinesNiacinamideSorafenib
Year: 2008 PMID: 19052134 DOI: 10.1056/NEJMc081780
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245